Recruitment

Recruitment Status
Completed

Inclusion Criterias

Patients must have had a hysterectomy (total abdominal, vaginal hysterectomy, or laparoscopic-assisted vaginal hysterectomy) or modified radical hysterectomy or radical hysterectomy and bilateral salpingo-oophorectomy no more than 8 weeks prior to start of radiation therapy.
Patients must have had a hysterectomy (total abdominal, vaginal hysterectomy, or laparoscopic-assisted vaginal hysterectomy) or modified radical hysterectomy or radical hysterectomy and bilateral salpingo-oophorectomy no more than 8 weeks prior to start of radiation therapy.

Exclusion Criterias

Positive peritoneal cytology only for stage IIIa (FIGO 1998).
With gross residual disease, or distant metastases.
with myometrial invasion <50%
...
Positive peritoneal cytology only for stage IIIa (FIGO 1998).
With gross residual disease, or distant metastases.
with myometrial invasion <50%
With serious internal diseases which affect designed treatment
Prior pelvic radiation therapy.
With psychotic disorders
Grade 1~2, with myometrial invasion >50%
With history of other malignancies less than 5 years.

Summary

Conditions
Prosthesis Survival
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Only females

Inclusion Criterias

Patients must have had a hysterectomy (total abdominal, vaginal hysterectomy, or laparoscopic-assisted vaginal hysterectomy) or modified radical hysterectomy or radical hysterectomy and bilateral salpingo-oophorectomy no more than 8 weeks prior to start of radiation therapy.
Patients must have had a hysterectomy (total abdominal, vaginal hysterectomy, or laparoscopic-assisted vaginal hysterectomy) or modified radical hysterectomy or radical hysterectomy and bilateral salpingo-oophorectomy no more than 8 weeks prior to start of radiation therapy.

Exclusion Criterias

Positive peritoneal cytology only for stage IIIa (FIGO 1998).
With gross residual disease, or distant metastases.
with myometrial invasion <50%
...
Positive peritoneal cytology only for stage IIIa (FIGO 1998).
With gross residual disease, or distant metastases.
with myometrial invasion <50%
With serious internal diseases which affect designed treatment
Prior pelvic radiation therapy.
With psychotic disorders
Grade 1~2, with myometrial invasion >50%
With history of other malignancies less than 5 years.

Locations

Shanghai, Shanghai, 200000
Shanghai, Shanghai, 200000

Tracking Information

NCT #
NCT01918124
Collaborators
Not Provided
Investigators
Study Chair: Huaying Wang, Doctor Shanghai Cancer Center